| Abstract: |
This is the sixth in a series of articles on presentations given at the American Diabetes Association’s 66th Scientific Sessions held in Washington, DC, in June 2006. In this entry, the author summarizes some of the presentations on diabetic retinopathy and neuropathy and lower extremity vascular disease. Topics include the use of insulin-like growth factor (IGF)-1 antagonists for treating diabetic retinopathy, octreotide, the relationship between dyslipidemia and diabetic retinopathy, the use of statins, the idea of the eye as a risk marker for cardiovascular disease (CVD), new therapies for diabetic retinopathy, drug therapy for patients with painful diabetic neuropathy, and the clinical syndrome and symptoms of diabetic neuropathy. The author includes results from the presentations and extensive references for readers wishing to obtain additional information. 45 references. |